High-Level Immunosuppression |
Treatment with glucocorticoids (prednisone >20 mg/day for ≥2 weeks and within 3 months of stopping therapy) |
Treatment with effective doses of 6-mercaptopurine, azathioprine, or methotrexate compared with those with low-level immunosuppression (described below) or discontinuation within 3 months |
Treatment with adalimumab, certolizumab pegol, golimumab, infliximab, natalizumab, or vedolizumab, or recent discontinuation within 3 months |
Low-Level Immunosuppression |
Treatment with lower total daily doses of corticosteroids compared with those with high-level immunosuppression for more than 14 days |
Patients receiving methotrexate (<0.4 mg/kg/week), azathioprine (<3.0 mg/kg/day), or mercaptopurine (<1.5 mg/kg/day) |